The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents

References

• Bray GA Medical consequences of obesity J Clin Endocrinol Metab 2004 89 2583 2589 15181027
   PubMed Web of Science ®Google Scholar
• WHO/Europe The challenge of obesity in the WHO European Region 2005 WHO Copenhagen, Bucharest
   Google Scholar
• WHO Obesity and overweight Geneva WHO 2006
   Google Scholar
• Wadden TA Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials Ann Intern Med 1993 119 688 693 8363198
   PubMed Web of Science ®Google Scholar
• Rosenbaum M Leibel RL The physiology of body weight regulation: relevance to the etiology of obesity in children Pediatrics 1998 101 525 539 12224659
   PubMed Web of Science ®Google Scholar
• Tong PC Lee ZS Sea MM The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes Arch Intern Med 2002 162 2428 2435 12437401
   PubMed Web of Science ®Google Scholar
• Wadden TA Berkowitz RI Sarwer DB Prus-Wisniewski R Steinberg C Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial Arch Intern Med 2001 161 218 227 11176735
   PubMed Web of Science ®Google Scholar
• Oster G Thompson D Edelsberg J Bird AP Colditz GA Lifetime health and economic benefits of weight loss among obese persons Am J Public Health 1999 89 1536 1542 10511836
   PubMed Web of Science ®Google Scholar
• Goldstein DJ Beneficial health effects of modest weight loss Int J Obes Relat Metab Disord 1992 16 397 415 1322866
   PubMed Web of Science ®Google Scholar
• Foster-Schubert KE Cummings DE Emerging therapeutic strategies for obesity Endocr Rev 2006 27 779 793 17122357
   PubMed Web of Science ®Google Scholar
• Halford JCG Cooper GD Dovey TM Ishii Y Rodgers RJ Blundell JE The psychopharmacology of appetite: targets for potential anti-obesity agents Curr Med Chem 2003 3 283 310
   Google Scholar
• Bray GA Greenway FL Current and potential drugs for treatment of obesity Endocr Rev 1999 20 805 875 10605627
   PubMed Web of Science ®Google Scholar
• Carey MC Hernell O Digestion and absorption of fat Semin Gastroint Dis 1992 3 189 208
   Google Scholar
• Carey MC Small DM Bliss CM Lipid digestion and absorption Annu Rev Physiol 1983 45 651 677 6342528
   PubMed Web of Science ®Google Scholar
• Nicolosi RJ Wilson TA Lawton C Handelman GJ Dietary effects on cardiovascular disease risk factors: beyond saturated fatty acids and cholesterol J Am Coll Nutr 2001 20 421S 427S 11603652
   PubMed Web of Science ®Google Scholar
• Mukherjee M Human digestive and metabolic lipases-a brief review J Mol Catal, B Enzym 2003 22 369 376
   Web of Science ®Google Scholar
• Birari RB Bhutani KK Pancreatic lipase inhibitors from natural sources: unexplored potential Drug Discov Today 2007 12 879 989 17933690
   PubMed Web of Science ®Google Scholar
• Hamosh M Lingual and gastric lipases: their role in fat digestion Boca Raton, FL CRC Press 1990
   Google Scholar
• Van Gaal L Mertens I Ballaux D Verkade HJ Modern, new pharmacotherapy for obesity. A gastrointestinal approach Best Pract Res Clin Gastroenterol 2004 18 1049 1072 15561638
   PubMed Web of Science ®Google Scholar
• Borgstrom B Erlanson-Albertsson C Hydrolysis of milk fat globules by pancreatic lipase. Role of colipase, phospholipase A2, and bile salts J Clin Invest 1982 70 30 32 7085886
   PubMed Web of Science ®Google Scholar
• Lowe ME The triglyceride lipases of the pancreas J Lipid Res 2002 43 2007 2016 12454260
   PubMed Web of Science ®Google Scholar
• Crenon I Foglizzo E Kerfelec B Pancreatic lipase-related protein type I: a specialized lipase or an inactive enzyme Protein Eng 1998 11 135 142 9605548
   PubMedGoogle Scholar
• Lowe ME Properties and function of pancreatic lipase related protein 2 Biochimie 2000 82 997 1004 11099796
   PubMed Web of Science ®Google Scholar
• Sias B Ferrato F Grandval P Human pancreatic lipase-related protein 2 is a galactolipase Biochemistry 2004 43 10138 10148 15287741
   PubMed Web of Science ®Google Scholar
• Reboul E Berton A Moussa M Kreuzer C Crenon I Borel P Pancreatic lipase and pancreatic lipase-related protein 2, but not pancreatic lipase-related protein 1, hydrolyze retinyl palmitate in physiological conditions Biochim Biophys Acta 2006 1761 4 10 16497549
   PubMed Web of Science ®Google Scholar
• Carriere F Barrowman JA Verger R Laugier R Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans Gastroenterology 1993 105 876 888 8359655
   PubMed Web of Science ®Google Scholar
• Armand M Borel P Dubois C Characterization of emulsions and lipolysis of dietary lipids in the human stomach Am J Physiol 1994 266 G372 G381 8166277
   PubMed Web of Science ®Google Scholar
• Armand M Borel P Pasquier B Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum Am J Physiol 1996 271 G172 G183 8760121
   PubMed Web of Science ®Google Scholar
• Armand M Pasquier B Andre M Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract Am J Clin Nutr 1999 70 1096 1106 10584056
   PubMed Web of Science ®Google Scholar
• Phan CT Tso P Intestinal lipid absorption and transport Front Biosci 2001 6 D299 D319 11229876
   PubMed Web of Science ®Google Scholar
• Thomson ABR De Pover A Keelan M Jarocka-Cyrta E Clandinin MT Inhibition of lipid absorption as an approach to the treatment of obesity Rubin B Dennis EA Methods in Enzymology Elsevier San Diego 1997 3 41
   Google Scholar
• Shi Y Burn P Lipid metabolic enzymes: emerging drug targets for the treatment of obesity Nat Rev Drug Discov 2004 3 695 710 15286736
   PubMed Web of Science ®Google Scholar
• van Tilbeurgh H Sarda L Verger R Cambillau C Structure of the pancreatic lipase-procolipase complex Nature 1992 359 159 162 1522902
   PubMed Web of Science ®Google Scholar
• Mu H Hoy CE The digestion of dietary triacylglycerols Prog Lipid Res 2004 43 105 133 14654090
   PubMed Web of Science ®Google Scholar
• Englyst KN Englyst HN Carbohydrate bioavailability Br J Nutr 2005 94 1 11 16115326
   PubMed Web of Science ®Google Scholar
• Cummings JH Macfarlane GT Englyst HN Prebiotic digestion and fermentation Am J Clin Nutr 2001 73 415S 420S 11157351
   PubMed Web of Science ®Google Scholar
• Grabitske HA Slavin JL Gastrointestinal effects of low-digestible carbohydrates Crit Rev Food Sci Nutr 2009 49 327 360 19234944
   PubMed Web of Science ®Google Scholar
• Hofbauer KG Molecular pathways to obesity Int J Obes Relat Metab Disord 2002 26 Suppl 2 S18 S27 12174325
   PubMed Web of Science ®Google Scholar
• Weigle DS Pharmacological therapy of obesity: Past, present, and future Clin Endocrinol Metab 2003 88 2462 2469
   Google Scholar
• Lissner L Heitmann BL Dietary fat and obesity: evidence from epidemiology Eur J Clin Nutr 1995 49 79 90 7743988
   PubMed Web of Science ®Google Scholar
• Klein S Long-term pharmacotherapy for obesity Obes Res 2004 12 Suppl 163S 166S 15687412
   PubMedGoogle Scholar
• Aronne LJ Obesity Med Clin North Am 1998 82 161 181 9457156
   PubMed Web of Science ®Google Scholar
• Miled N Canaan S Dupuis L Digestive lipases: from three-dimensional structure to physiology Biochimie 2000 82 973 986 11099794
   PubMed Web of Science ®Google Scholar
• Ayvazian L Kerfelec B Granon S The lipase C-terminal domain. A novel unusual inhibitor of pancreatic lipase activity J Biol Chem 2001 276 14014 14018 11154696
   PubMed Web of Science ®Google Scholar
• Sebban-Kreuzer C Ayvazian L Juhel C Salles JP Chapus C Kerfelec B Inhibitory effect of the pancreatic lipase C-terminal domain on intestinal lipolysis in rats fed a high-fat diet: chronic study Int J Obes Relat Metab Disord 2003 27 319 325 12629558
   PubMed Web of Science ®Google Scholar
• Yamada Y Kato T Ogino H Ashina S Kato K Cetilistat (ATL-962), a novel pancreatic lipase inhibitor, ameliorates body weight gain and improves lipid profiles in rats Horm Metab Res 2008 40 539 543 18500680
   PubMed Web of Science ®Google Scholar
• Bryson A de la Motte S Dunk C Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers Br J Clin Pharmacol 2009 67 309 315 19220279
   PubMed Web of Science ®Google Scholar
• Kopelman P Bryson A Hickling R Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients Int J Obes (Lond) 2007 31 494 499 16953261
   PubMed Web of Science ®Google Scholar
• Kopelman P de HGG Rissanen A Weight loss, HbA(1c) reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical) Obesity (Silver Spring) 2010 18 108 115 19461584
   PubMed Web of Science ®Google Scholar
• Slanc P Doljak B Kreft S Lunder M Janes D Strukelj B Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition Phytother Res 2009 23 874 877 19107742
   PubMed Web of Science ®Google Scholar
• Hostettmann K Marston A Saponins Cambridge Cambridge University Press 1995 560
   Google Scholar
• Jiang W Li W Han L Biologically active triterpenoid saponins from Acanthopanax senticosus J Nat Prod 2006 69 1577 1581 17125224
   PubMed Web of Science ®Google Scholar
• Yoshizumi K Hirano K Ando H Lupane-type saponins from leaves of Acanthopanax sessiliflorus and their inhibitory activity on pancreatic lipase J Agric Food Chem 2006 54 335 341 16417288
   PubMed Web of Science ®Google Scholar
• Liu W Zheng Y Han L Saponins (Ginsenosides) from stems and leaves of Panax quinquefolium prevented high-fat diet-induced obesity in mice Phytomedicine 2008 15 1140 1145 18768305
   PubMed Web of Science ®Google Scholar
• Fujikawa T Yamaguchi A Morita I Takeda H Nishibe S Protective effects of Acanthopanax senticosus Harms from Hokkaido and its components on gastric ulcer in restrained cold water stressed rats Biol Pharm Bull 1996 19 1227 1230 8889047
   PubMed Web of Science ®Google Scholar
• Gaffney BT Hugel HM Rich PA Panax ginseng and Eleutherococcus senticosus may exaggerate an already existing biphasic response to stress via inhibition of enzymes which limit the binding of stress hormones to their receptors Med Hypotheses 2001 56 567 572 11388770
   PubMed Web of Science ®Google Scholar
• Yi JM Hong SH Kim JH Kim HK Song HJ Kim HM Effect of Acanthopanax senticosus stem on mast cell-dependent anaphylaxis J Ethnopharmacol 2002 79 347 352 11849840
   PubMed Web of Science ®Google Scholar
• Jung HJ Park HJ Kim RG In vivo anti-inflammatory and antinociceptive effects of liriodendrin isolated from the stem bark of Acanthopanax senticosus Planta Med 2003 69 610 616 12898415
   PubMed Web of Science ®Google Scholar
• Deyama T Nishibe S Nakazawa Y Constituents and pharmacological effects of Eucommia and Siberian ginseng Acta Pharmacol Sin 2001 22 1057 1070 11749801
   PubMed Web of Science ®Google Scholar
• Brekhman II Dardymov IV New substances of plant origin which increase nonspecific resistance Annu Rev Pharmacol 1969 9 419 430 4892434
   PubMedGoogle Scholar
• Li F Li W Fu H Zhang Q Koike K Pancreatic lipase-inhibiting triterpenoid saponins from fruits of Acanthopanax senticosus Chem Pharm Bull (Tokyo) 2007 55 1087 1089 17603209
   PubMed Web of Science ®Google Scholar
• Cha YS Soh JR Kim JW Acanthopanax senticosus extract prepared from cultured cells improves lipid parameters in rats fed with a high fat diet J Korean Soc Nutraceut Food 2003 8 40 45
   Google Scholar
• Cha YS Rhee SJ Heo YR Acanthopanax senticosus extract prepared from cultured cells decreases adiposity and obesity indices in C57BL/6J mice fed a high fat diet J Med Food 2004 7 422 429 15671684
   PubMed Web of Science ®Google Scholar
• Lee YJ Chung HY Kwak HK Yoon S The effects of A. senticosus supplementation on serum lipid profiles, biomarkers of oxidative stress, and lymphocyte DNA damage in postmenopausal women Biochem Biophys Res Commun 2008 375 44 48 18671947
   PubMed Web of Science ®Google Scholar
• Park SH Lee SG Kang SK Chung SH Acanthopanax senticosus reverses fatty liver disease and hyperglycemia in ob/ob mice Arch Pharm Res 2006 29 768 776 17024851
   PubMed Web of Science ®Google Scholar
• Yoshizumi K Murota K Watanabe S Tomi H Tsuji T Terao J Chiisanoside is not absorbed but inhibits oil absorption in the small intestine of rodents Biosci Biotechnol Biochem 2008 72 1126 1129 18391464
   PubMed Web of Science ®Google Scholar
• Qian XZ Colored Illustrations of Chinese Herbs: Part II Beijing People’s Health Press 1996
   Google Scholar
• Kimura H Ogawa S Katsube T Jisaka M Yokota K Antiobese effects of novel saponins from edible seeds of Japanese horse chestnut (Aesculus turbinata BLUME) after treatment with wood ashes J Agric Food Chem 2008 56 4783 4788 18512932
   PubMed Web of Science ®Google Scholar
• Hu JN Zhu XM Han LK Anti-obesity effects of escins extracted from the seeds of Aesculus turbinata BLUME (Hippocastanaceae) Chem Pharm Bull (Tokyo) 2008 56 12 16 18175967
   PubMed Web of Science ®Google Scholar
• Kimura H Ogawa S Jisaka M Kimura Y Katsube T Yokota K Identification of novel saponins from edible seeds of Japanese horse chestnut (Aesculus turbinata Blume) after treatment with wooden ashes and their nutraceutical activity J Pharm Biomed Anal 2006 41 1657 1665 16621416
   PubMed Web of Science ®Google Scholar
• Yoshikawa M Sugimoto S Kato Y Acylated oleanane-type triterpene saponins with acceleration of gastrointestinal transit and inhibitory effect on pancreatic lipase from flower buds of chinese tea plant (Camellia sinensis) Chem Biodivers 2009 6 903 915 19551732
   PubMed Web of Science ®Google Scholar
• Kwon CS Sohn HY Kim SH Anti-obesity effect of Dioscorea nipponica Makino with lipase-inhibitory activity in rodents Biosci Biotechnol Biochem 2003 67 1451 1456 12913286
   PubMed Web of Science ®Google Scholar
• Han LK Kimura Y Kawashima M Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor Int J Obes 2001 25 1459 1464
   PubMed Web of Science ®Google Scholar
• Han LK Takaku T Li J Kimura Y Okuda H Anti-obesity action of oolong tea Int J Obes Relat Metab Disord 1999 23 98 105 10094584
   PubMed Web of Science ®Google Scholar
• Leonhardt M Hrupka B Langhans W New approaches in the pharmacological treatment of obesity Eur J Nutr 1999 38 1 13 10338682
   PubMed Web of Science ®Google Scholar
• Han LK Zheng YN Yoshikawa M Okuda H Kimura Y Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes BMC Complement Altern Med 2005 5 9 15811191
   PubMedGoogle Scholar
• Hiroahi I Kauzuo T Yohko Y Saponins from the roots of Platycodon grandiflorum. Part 1: structure of prosapogenins J Chem Soc Perkin Trans 1981 1928 1933
   Google Scholar
• Kim KS Ezaki O Ikemoto S Itakura H Effects of Platycodon grandiflorum feeding on serum and liver lipid concentrations in rats with diet-induced hyperlipidemia J Nutr Sci Vitaminol (Tokyo) 1995 41 485 491 8676221
   PubMed Web of Science ®Google Scholar
• Xu BJ Han LK Zheng YN Lee JH Sung CK In vitro inhibitory effect of triterpenoidal saponins from Platycodi Radix on pancreatic lipase Arch Pharm Res 2005 28 180 185 15789748
   PubMed Web of Science ®Google Scholar
• Han L Zheng Y Xu B Okuda H Kimura Y Saponins from Platycodi radix ameliorate high fat diet-induced obesity in mice J Nutr 2002 132 2241 2245 12163669
   PubMed Web of Science ®Google Scholar
• Han LK Xu BJ Kimura Y Zheng Y Okuda H Platycodi radix affects lipid metabolism in mice with high fat diet-induced obesity J Nutr 2000 130 2760 2764 11053518
   PubMed Web of Science ®Google Scholar
• Zhao HL Kim YS Determination of the kinetic properties of platycodin D for the inhibition of pancreatic lipase using a 1,2-diglyceride-based colorimetric assay Arch Pharm Res 2004 27 1048 1052 15554263
   PubMed Web of Science ®Google Scholar
• Zhao HL Sim JS Ha YW Kang SS Kim YS Antiobese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: evidences for lipase inhibition and calorie intake restriction Int J Obes (Lond) 2005 29 983 990 15852049
   PubMed Web of Science ®Google Scholar
• Lee EB Pharmacological activities of crude platycodin J Pharmaceut Soc Korea 1975 19 164 176
   Google Scholar
• Chung MS Kim NC Long L Dereplication of saccharide and polyol constituents of candidate sweet-tasting plants: isolation of the sesquiterpene glycoside mukurozioside IIb as a sweet principle of Sapindus rarak Phytochemical Analysis 1997 8 49 54
   Web of Science ®Google Scholar
• Morikawa T Xie Y Asao Y Oleanane-type triterpene oligoglycosides with pancreatic lipase inhibitory activity from the pericarps of Sapindus rarak Phytochemistry 2009 70 1166 1172 19647280
   PubMed Web of Science ®Google Scholar
• Zheng Q Koike K Han LK Okuda H Nikaido T New biologically active triterpenoid saponins from Scabiosa tschiliensis J Nat Prod 2004 67 604 613 15104490
   PubMed Web of Science ®Google Scholar
• Guo T Liu Q Wang P Zhang L Zhang W Li Y Facile synthesis of three bidesmosidic oleanolic acid saponins with strong inhibitory activity on pancreatic lipase Carbohydr Res 2009 344 1167 1174 19463989
   PubMed Web of Science ®Google Scholar
• Arts IC Hollman PC Polyphenols and disease risk in epidemiologic studies Am J Clin Nutr 2005 81 317S 325S 15640497
   PubMed Web of Science ®Google Scholar
• Griffiths DW The inhibition of digestive enzymes by polyphenolic compounds Adv Exp Med Biol 1986 199 509 516 3799290
   PubMedGoogle Scholar
• Horigome T Kumar R Okamoto K Effects of condensed tannins prepared from leaves of fodder plants on digestive enzymes in vitro and in the intestine of rats Br J Nutr 1988 60 275 285 2461730
   PubMed Web of Science ®Google Scholar
• Al-Mamary M Al-Aghbari A Al-Habori M Al-Obeidi A In vivo effects of dietary sorghum tannins on rabbit digestive enzymes and mineral absorption Nutr Res 2001 21 1393 1401
   Web of Science ®Google Scholar
• Nonaka G Hsu F Nishioka I Structures of dimeric, trimeric, and tetrameric procyanidins from Areca catechu L J Chem Soc Chem Commun 1981 781 784
   Google Scholar
• Leontowicz H Gorinstein S Lojek A Comparative content of some bioactive compounds in apples, peaches and pears and their influence on lipids and antioxidant capacity in rats J Nutr Biochem 2002 13 603 610 12550072
   PubMed Web of Science ®Google Scholar
• Akiyama H Sato Y Watanabe T Dietary unripe apple polyphenol inhibits the development of food allergies in murine models FEBS Lett 2005 579 4485 4491 16081068
   PubMed Web of Science ®Google Scholar
• Gosse F Guyot S Roussi S Chemopreventive properties of apple procyanidins on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis Carcinogenesis 2005 26 1291 1295 15790589
   PubMed Web of Science ®Google Scholar
• Sugiyama H Akazome Y Shoji T Oligomeric procyanidins in apple polyphenol are main active components for inhibition of pancreatic lipase and triglyceride absorption J Agric Food Chem 2007 55 4604 4609 17458979
   PubMed Web of Science ®Google Scholar
• Yamamoto M Shimura S Itoh Y Ohsaka T Egawa M Inoue S Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet Int J Obes Relat Metab Disord 2000 24 758 764 10878683
   PubMed Web of Science ®Google Scholar
• Ardevol A Blade C Salvado MJ Arola L Changes in lipolysis and hormone-sensitive lipase expression caused by procyanidins in 3T3-L1 adipocytes Int J Obes Relat Metab Disord 2000 24 319 324 10757625
   PubMed Web of Science ®Google Scholar
• de Freitas VA Glories Y Laguerre M Incidence of Molecular Structure in Oxidation of Grape Seed Procyanidins J Agric Food Chem 1998 46 376 382 10554249
   PubMed Web of Science ®Google Scholar
• Moreno DA Ilic N Poulev A Brasaemle DL Fried SK Raskin I Inhibitory effects of grape seed extract on lipases Nutrition 2003 19 876 879 14559324
   PubMed Web of Science ®Google Scholar
• Yamakoshi J Saito S Kataoka S Kikuchi M Safety evaluation of proanthocyanidin-rich extract from grape seeds Food Chem Toxicol 2002 40 599 607 11955665
   PubMed Web of Science ®Google Scholar
• Thorsen MA Hildebrandt KS Quantitative determination of phenolic diterpenes in rosemary extracts. Aspects of accurate quantification J Chromatogr A 2003 995 119 125 12800928
   PubMed Web of Science ®Google Scholar
• Ninomiya K Matsuda H Shimoda H Carnosic acid, a new class of lipid absorption inhibitor from sage Bioorg Med Chem Lett 2004 14 1943 1946 15050633
   PubMed Web of Science ®Google Scholar
• Machida K Oyama K Ishii M Kakuda R Yaoita Y Kikuchi M Studies of the constituents of Gardenia species. II. Terpenoids from Gardeniae Fructus Chem Pharm Bull (Tokyo) 2000 48 746 748 10823717
   PubMed Web of Science ®Google Scholar
• Mathews-Roth MM Effect of crocetin on experimental skin tumors in hairless mice Oncology 1982 39 362 364 6813784
   PubMed Web of Science ®Google Scholar
• Abe K Sugiura M Shoyama Y Saito H Crocin antagonizes ethanol inhibition of NMDA receptor-mediated responses in rat hippocampal neurons Brain Res 1998 787 132 138 9518580
   PubMed Web of Science ®Google Scholar
• Ochiai T Ohno S Soeda S Tanaka H Shoyama Y Shimeno H Crocin prevents the death of rat pheochromyctoma (PC-12) cells by its antioxidant effects stronger than those of alpha-tocopherol Neurosci Lett 2004 362 61 64 15147781
   PubMed Web of Science ®Google Scholar
• Lee IA Lee JH Baek NI Kim DH Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite Crocetin Biol Pharm Bull 2005 28 2106 2110 16272698
   PubMed Web of Science ®Google Scholar
• Weibel EK Hadvary P Hochuli E Kupfer E Lengsfeld H Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity J Antibiot (Tokyo) 1987 40 1081 1085 3680018
   PubMed Web of Science ®Google Scholar
• Guerciolini R Mode of action of orlistat Int J Obes Relat Metab Disord 1997 21 Suppl 3 S12 S23 9225172
   PubMed Web of Science ®Google Scholar
• Hadvary P Sidler W Meister W Vetter W Wolfer H The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase J Biol Chem 1991 266 2021 2027 1899234
   PubMed Web of Science ®Google Scholar
• Carriere F Renou C Ransac S Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers Am J Physiol Gastrointest Liver Physiol 2001 281 G16 G28 11408251
   PubMed Web of Science ®Google Scholar
• Sternby B Hartmann D Borgstrom B Nilsson A Degree of in vivo inhibition of human gastric and pancreatic lipases by Orlistat (Tetrahydrolipstatin, THL) in the stomach and small intestine Clin Nutr 2002 21 395 402 12381337
   PubMed Web of Science ®Google Scholar
• Halford JCG Pharmacotherapy for obesity Appetite 2006 6 10 16229924
   PubMed Web of Science ®Google Scholar
• Zhi J Melia AT Guerciolini R Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers Clin Pharmacol Ther 1994 56 82 85 8033498
   PubMed Web of Science ®Google Scholar
• Fernandez E Borgstrom B Effects of tetrahydrolipstatin, a lipase inhibitor, on absorption of fat from the intestine of the rat Biochim Biophys Acta 1989 1001 249 255 2917150
   PubMed Web of Science ®Google Scholar
• Hauptman JB Jeunet FS Hartmann D Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18–0647 (tetrahydrolipstatin) Am J Clin Nutr 1992 55 309S 313S 1728845
   PubMed Web of Science ®Google Scholar
• Hussain Y Guzelhan C Odink J van der Beek EJ Hartmann D Comparison of the inhibition of dietary fat absorption by full versus divided doses of orlistat J Clin Pharmacol 1994 34 1121 1125 7876405
   PubMed Web of Science ®Google Scholar
• Sjostrom L Rissanen A Andersen T Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group Lancet 1998 352 167 172 9683204
   PubMed Web of Science ®Google Scholar
• Torgerson JS Hauptman J Boldrin MN Sjostrom L Xenical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients Diabetes Care 2004 27 155 161 14693982
   PubMed Web of Science ®Google Scholar
• Rossner S Sjostrom L Noack R Meinders AE Noseda G Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group Obes Res 2000 8 49 61 10678259
   PubMedGoogle Scholar
• Scheen AJ Ernest P New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat Diabetes Metab 2002 28 437 445 12522323
   PubMed Web of Science ®Google Scholar
• Karhunen L Franssila-Kallunki A Rissanen P Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns Int J Obes Relat Metab Disord 2000 24 1567 1572 11126207
   PubMed Web of Science ®Google Scholar
• Ballinger A Peikin SR Orlistat: its current status as an anti-obesity drug Eur J Pharmacol 2002 440 109 117 12007529
   PubMed Web of Science ®Google Scholar
• Melia AT Zhi J Koss-Twardy SG The influence of reduced dietary fat absorption induced by orlistat on the pharmacokinetics of digoxin in healthy volunteers J Clin Pharmacol 1995 35 840 843 8522642
   PubMed Web of Science ®Google Scholar
• O’Donovan D Horowitz M Russo A Effects of lipase inhibition on gastric emptying of, and on the glycaemic, insulin and cardiovascular responses to, a high-fat/carbohydrate meal in type 2 diabetes Diabetologia 2004 47 2208 2214 15662558
   PubMed Web of Science ®Google Scholar
• Filippatos TD Derdemezis CS Gazi IF Nakou ES Mikhailidis DP Elisaf MS Orlistat-associated adverse effects and drug interactions: a critical review Drug Saf 2008 31 53 65 18095746
   PubMed Web of Science ®Google Scholar
• Beaver J Bell JD Thomas EL Orlistat 60 mg in conjunction with diet provides significant reduction in visceral adipose tissue 1st International Congress on Abdominal Obesity Hong Kong 2010
   Google Scholar
• Greenway F Smith SR Murray K Orlistat 60 mg demonstrates a significant reduction in visceral adipose tissue at 24 weeks compared with placebo 1st International Congress on Abdominal Obesity Hong Kong 2010
   Google Scholar
• Mutoh M Nakada N Matsukuma S Panclicins, novel pancreatic lipase inhibitors. I. Taxonomy, fermentation, isolation and biological activity J Antibiot (Tokyo) 1994 47 1369 1375 7844031
   PubMed Web of Science ®Google Scholar
• Nonaka Y Ohtaki H Ohtsuka E Effects of ebelactone B, a lipase inhibitor, on intestinal fat absorption in the rat J Enzyme Inhib 1996 10 57 63 8835930
   PubMedGoogle Scholar
• Liu DZ Wang F Liao TG Vibralactone: a lipase inhibitor with an unusual fused beta-lactone produced by cultures of the basidiomycete Boreostereum vibrans Org Lett 2006 8 5749 5752 17134263
   PubMed Web of Science ®Google Scholar
• Jain NK Boivin M Zinsmeister AR Brown ML Malagelada JR DiMagno EP Effect of ileal perfusion of carbohydrates and amylase inhibitor on gastrointestinal hormones and emptying Gastroenterology 1989 96 377 387 2463204
   PubMed Web of Science ®Google Scholar
• Jain NK Boivin M Zinsmeister AR DiMagno EP The ileum and carbohydrate-mediated feedback regulation of postprandial pancreaticobiliary secretion in normal humans Pancreas 1991 6 495 505 1719522
   PubMed Web of Science ®Google Scholar
• Salvatore T Giugliano D Pharmacokinetic-pharmacodynamic relationships of Acarbose Clin Pharmacokinet 1996 30 94 106 8906894
   PubMed Web of Science ®Google Scholar
• Hildebrand I Boehme K Frank G Fink H Berchtold P The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on post-prandial blood glucose, serum insulin, and triglyceride levels: dose-time- response relationships in man Res Exp Med 1979 175 87 94
   Google Scholar
• Samulitis BK Goda T Lee SM Koldovsky O Inhibitory mechanism of acarbose and 1-deoxynojirimycin derivatives on carbohydrases in rat small intestine Drugs Exp Clin Res 1987 13 517 524 2962844
   PubMedGoogle Scholar
• Puls W Keup U Krause HP Thomas G Pharmacological significance of glucosidase inhibitors (acarbose) Regulators of intestinal absorption in obesity, diabetes and nutrition in Regulators of intestinal absorption in obesity, diabetes and nutrition Proceedings of Satellite Symposium n 7 Third International Congress on Obesity Siena, Italy Societa Editrice Universo 1981
   Google Scholar
• William-Olsson T alpha-Glucosidase inhibition in obesity Acta Med Scand Suppl 1985 706 1 39 3914827
   PubMedGoogle Scholar
• Wolever TM Chiasson JL Josse RG Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes Int J Obes Relat Metab Disord 1997 21 756 763 9376887
   PubMed Web of Science ®Google Scholar
• Sonmez AS Yasar L Savan K Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome Hum Reprod 2005 20 175 179 15513975
   PubMed Web of Science ®Google Scholar
• Penna IA Canella PR Reis RM Silva de Sa MF Ferriani RA Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study Hum Reprod 2005 20 2396 2401 16006454
   PubMed Web of Science ®Google Scholar
• Tugrul S Kutlu T Pekin O Baglam E Kiyak H Oral O Clinical, endocrine, and metabolic effects of acarbose, a alpha-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome Fertil Steril 2008 90 1144 1148 18377903
   PubMed Web of Science ®Google Scholar
• Asano N Yamashita T Yasuda K Polyhydroxylated alkaloids isolated from mulberry trees (Morusalba L.) and silkworms (Bombyx mori L.) J Agric Food Chem 2001 49 4208 4213 11559112
   PubMed Web of Science ®Google Scholar
• Kong WH Oh SH Ahn YR Kim KW Kim JH Seo SW Antiobesity effects and improvement of insulin sensitivity by 1-deoxynojirimycin in animal models J Agric Food Chem 2008 56 2613 2619 18363357
   PubMed Web of Science ®Google Scholar
• Madar Z Olefsky J Effect of the alpha-glucosidase inhibitor Bay-O- 1248 on the metabolic response of nondiabetic and diabetic rats to a high-carbohydrate diet Am J Clin Nutr 1986 44 206 211 3728357
   PubMed Web of Science ®Google Scholar
• Cauderay M Tappy L Temler E Jequier E Hillebrand I Felber JP Effect of alpha-glycohydrolase inhibitors (Bay m1099 and Bay o1248) on sucrose metabolism in normal men Metabolism 1986 35 472 477 3517560
   PubMed Web of Science ®Google Scholar
• Hillebrand I Boehme K Graefe KH Wehling K The effect of new alpha-glucosidase inhibitors (BAY m 1099 and BAY o 1248) on meal-stimulated increases in glucose and insulin levels in man Klin Wochenschr 1986 64 393 396 3517475
   PubMedGoogle Scholar
• Hansawasdi C Kawabata J Kasai T Alpha-amylase inhibitors from roselle (Hibiscus sabdariffa Linn.) tea Biosci Biotechnol Biochem 2000 64 1041 1043 10879476
   PubMed Web of Science ®Google Scholar
• Matsui T Yoshimoto C Osajima K Oki T Osajima Y In vitro survey of alpha-glucosidase inhibitory food components Biosci Biotechnol Biochem 1996 60 2019 2022 8988634
   PubMed Web of Science ®Google Scholar
• Kobayashi Y Suzuki M Satsu H Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism J Agric Food Chem 2000 48 5618 5623 11087528
   PubMed Web of Science ®Google Scholar
• Zhong L Furne JK Levitt MD An extract of black, green, and mulberry teas causes malabsorption of carbohydrate but not of triacylglycerol in healthy volunteers Am J Clin Nutr 2006 84 551 555 16960168
   PubMed Web of Science ®Google Scholar
• Marshall JJ Lauda CM Purification and properties of phaseolamin, an inhibitor of alpha-amylase, from the kidney bean, Phaseolus vulgaris J Biol Chem 1975 250 8030 8037 240849
   PubMed Web of Science ®Google Scholar
• Hollenbeck CB Coulston AM Quan R Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies Am J Clin Nutr 1983 38 498 503 6414283
   PubMed Web of Science ®Google Scholar
• Kotaru M Iwami K Yeh HY Ibuki F In vivo action of alpha-amylase inhibitor from cranberry bean (Phaseolus vulgaris) in rat small intestine J Nutr Sci Vitaminol (Tokyo) 1989 35 579 588 2699495
   PubMed Web of Science ®Google Scholar
• Tormo MA Gil-Exojo I Romero de Tejada A Campillo JE Hypoglycaemic and anorexigenic activities of an alpha-amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistar rats Br J Nutr 2004 92 785 790 15533267
   PubMed Web of Science ®Google Scholar
• Tormo MA Gil-Exojo I Romero de Tejada A Campillo JE White bean amylase inhibitor administered orally reduces glycaemia in type 2 diabetic rats Br J Nutr 2006 96 539 544 16925860
   PubMed Web of Science ®Google Scholar
• Jaffe WG Lette CL Heat-labile growth-inhibiting factors in beans (Phaseolus vulgaris) J Nutr 1968 94 203 210 4966063
   PubMed Web of Science ®Google Scholar
• Pusztai A Grant G Duguid T Inhibition of starch digestion by alpha-amylase inhibitor reduces the efficiency of utilization of dietary proteins and lipids and retards the growth of rats J Nutr 1995 125 1554 1562 7782910
   PubMed Web of Science ®Google Scholar
• Fantini N Cabras C Lobina C Reducing Effect of a Phaseolus vulgaris dry extract on food intake, body weight, and glycemia in rats J Agric Food Chem 2009 14 9316 9323 19731962
   PubMed Web of Science ®Google Scholar
• Maranesi M Carenini G Gentili P Nutritional studies on anti alphaamylase: I) Influence on the growth rate, blood picture and biochemistry and histological parameters in rats Acta Vitaminol Enzymol 1984 6 259 269 6335947
   PubMedGoogle Scholar
• Bo-Linn GW Santa Ana CA Morawski SG Fordtran JS Starch blockers–their effect on calorie absorption from a high-starch meal N Engl J Med 1982 307 1413 1416 6182469
   PubMed Web of Science ®Google Scholar
• Carlson GL Li BU Bass P Olsen WA A bean alpha-amylase inhibitor formulation (starch blocker) is ineffective in man Science 1983 219 393 395 6184780
   PubMed Web of Science ®Google Scholar
• Udani J Hardy M Madsen DC Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract Altern Med Rev 2004 9 63 69 15005645
   PubMedGoogle Scholar
• Layer P Carlson GL DiMagno EP Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans Gastroenterology 1985 88 1895 1902 2581844
   PubMed Web of Science ®Google Scholar
• Vinson J Investigation on the efficacy of Phaseolamin 2250, a purified bean extract from Pharmachem Laboratories University of Scranton 2001
   Google Scholar
• Layer P Rizza RA Zinsmeister AR Carlson GL DiMagno EP Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus Mayo Clin Proc 1986 61 442 447 2423813
   PubMed Web of Science ®Google Scholar
• Vinson JA Al Kharrat H Shuta D Investigation of an Amylase Inhibitor on Human Glucose Absorption after Starch Consumption The Open Nutraceuticals Journal 2009 2 88 91
   Google Scholar
• Meiss DE Ballerini R Effectiveness of Phase 2™, a natural alpha-amylase inhibitor, for weight loss: a randomized double-blind, placebo-controlled study Scripps Clinic Natural Supplements in Evidence-Based Practice Conference 2003
   Google Scholar
• Celleno L Tolaini MV D’Amore A Perricone NV Preuss HG A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women Int J Med Sci 2007 4 45 52 17299581
   PubMedGoogle Scholar
• Udani J Singh BB Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract Altern Ther Health Med 2007 13 32 37 17658120
   PubMed Web of Science ®Google Scholar
• Broadhurst CL Polansky MM Anderson RA Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro J Agric Food Chem 2000 48 849 852 10725162
   PubMed Web of Science ®Google Scholar
• Jayaprakasam B Vareed SK Olson LK Nair MG Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits J Agric Food Chem 2005 53 28 31 15631504
   PubMed Web of Science ®Google Scholar
• McDougall GJ Stewart D The inhibitory effects of berry polyphenols on digestive enzymes Biofactors 2005 23 189 195 16498205
   PubMed Web of Science ®Google Scholar
• Maatta-Riihinen KR Kamal-Eldin A Mattila PH Gonzalez-Paramas AM Torronen AR Distribution and contents of phenolic compounds in eighteen Scandinavian berry species J Agric Food Chem 2004 52 4477 4486 15237955
   PubMed Web of Science ®Google Scholar
• Hsu TF Kusumoto A Abe K Polyphenol-enriched oolong tea increases fecal lipid excretion Eur J Clin Nutr 2006 60 1330 1336 16804556
   PubMed Web of Science ®Google Scholar
• Tsuda T Regulation of adipocyte function by anthocyanins; possibility of preventing the metabolic syndrome J Agric Food Chem 2008 56 642 646 18211021
   PubMed Web of Science ®Google Scholar
• Sakurai T Nishimura T Otake N Assamicin I and II, novel triterpenoid saponins with insulin-like activity from Aesculus assamica Griff Bioorg Med Chem Lett 2002 12 807 810 11859008
   PubMed Web of Science ®Google Scholar
• Kurihara H Asami S Shibata H Fukami H Tanaka T Hypolipemic effect of Cyclocarya paliurus (Batal) Iljinskaja in lipid-loaded mice Biol Pharm Bull 2003 26 383 385 12612454
   PubMed Web of Science ®Google Scholar
• Kurihara H Kusumoto A Toyoda Y Hypoglycemic action of Cyclocarya paliurus (Batal.) Iljinskaja in normal and diabetic mice Biosci Biotechnol Biochem 2003 67 877 880 12784631
   PubMed Web of Science ®Google Scholar
• Balentine DA Wiseman SA Bouwens LC The chemistry of tea flavonoids Crit Rev Food Sci Nutr 1997 37 693 704 9447270
   PubMed Web of Science ®Google Scholar
• Wolfram S Wang Y Thielecke F Anti-obesity effects of green tea: from bedside to bench Mol Nutr Food Res 2006 50 176 187 16470636
   PubMed Web of Science ®Google Scholar
• Thielecke F Boschmann M The potential role of green tea catechins in the prevention of the metabolic syndrome – a review Phytochemistry 2009 70 11 24 19147161
   PubMed Web of Science ®Google Scholar
• Sano M Tabata M Suzuki M Degawa M Miyase T Maeda-Yamamoto M Simultaneous determination of twelve tea catechins by high-performance liquid chromatography with electrochemical detection Analyst 2001 126 816 820 11445943
   PubMed Web of Science ®Google Scholar
• Mandel SA Amit T Weinreb O Reznichenko L Youdim MB Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases CNS Neurosci Ther 2008 14 352 365 19040558
   PubMed Web of Science ®Google Scholar
• Wolfram S Raederstorff D Wang Y Teixeira SR Elste V Weber P TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass Ann Nutr Metab 2005 49 54 63 15735368
   PubMed Web of Science ®Google Scholar
• Furuyashiki T Nagayasu H Aoki Y Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPAR-gamma2 and C/EBPalpha in 3T3-L1 cells Biosci Biotechnol Biochem 2004 68 2353 2359 15564676
   PubMed Web of Science ®Google Scholar
• Hung PF Wu BT Chen HC Antimitogenic effect of green tea (–)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways Am J Physiol Cell Physiol 2005 288 C1094 C1108 15647388
   PubMed Web of Science ®Google Scholar
• Shimizu M Kobayashi Y Suzuki M Satsu H Miyamoto Y Regulation of intestinal glucose transport by tea catechins Biofactors 2000 13 61 65 11237201
   PubMed Web of Science ®Google Scholar
• Matsumoto N Ishigaki F Ishigaki A Iwashina H Hara Y Reduction of blood glucose levels by tea catechin Biosci Biotechnol Biochem 1993 57 525 527
   PubMed Web of Science ®Google Scholar
• Juhel C Armand M Pafumi Y Rosier C Vandermander J Lairon D Green tea extract (AR25) inhibits lipolysis of triglycerides in gastric and duodenal medium in vitro J Nutr Biochem 2000 11 45 51 15539342
   PubMed Web of Science ®Google Scholar
• Juskiewicz J Zdunczyk Z Jurgonski A Brzuzan L Godycka-Klos I Zary-Sikorska E Extract of green tea leaves partially attenuates streptozotocin- induced changes in antioxidant status and gastrointestinal functioning in rats Nutr Res 2008 28 343 349 19083430
   PubMed Web of Science ®Google Scholar
• Sogawa M Seura T Kohno S Awa (Tokushima) lactate- fermented tea as well as green tea enhance the effect of diet restriction on obesity in rats J Med Invest 2009 56 42 48 19262013
   PubMedGoogle Scholar
• Chantre P Lairon D Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity Phytomedicine 2002 9 3 8 11924761
   PubMed Web of Science ®Google Scholar
• Mukherjee PK Saha K Das J Pal M Saha BP Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera Planta Med 1997 63 367 369 9270384
   PubMed Web of Science ®Google Scholar
• Sinha S Mukherjee PK Mukherjee K Pal M Mandal SC Saha BP Evaluation of antipyretic potential of Nelumbo nucifera stalk extract Phytother Res 2000 14 272 274 10861971
   PubMed Web of Science ®Google Scholar
• Jung HA Kim JE Chung HY Choi JS Antioxidant principles of Nelumbo nucifera stamens Arch Pharm Res 2003 26 279 285 12735685
   PubMed Web of Science ®Google Scholar
• Ono Y Hattori E Fukaya Y Imai S Ohizumi Y Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats J Ethnopharmacol 2006 106 238 244 16495025
   PubMed Web of Science ®Google Scholar
• Mukherjee PK Saha K Pal M Saha BP Effect of Nelumbo nucifera rhizome extract on blood sugar level in rats J Ethnopharmacol 1997 58 207 213 9421256
   PubMed Web of Science ®Google Scholar
• Muramatsu K Fukuyo M Hara Y Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats J Nutr Sci Vitaminol (Tokyo) 1986 32 613 622 3585557
   PubMed Web of Science ®Google Scholar
• Ikeda I Imasato Y Sasaki E Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats Biochim Biophys Acta 1992 1127 141 146 1643098
   PubMed Web of Science ®Google Scholar
• Nakai M Fukui Y Asami S Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro J Agric Food Chem 2005 53 4593 4598 15913331
   PubMed Web of Science ®Google Scholar
• Nagao T Komine Y Soga S Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men Am J Clin Nutr 2005 81 122 129 15640470
   PubMed Web of Science ®Google Scholar
• Irshad M Sharma CB Purification and properties of an alpha-amylase protein-inhibitor from Arachis hypogaea seeds Biochim Biophys Acta 1981 659 326 333 6167287
   PubMed Web of Science ®Google Scholar
• Hochstrasser K Feuth H Werle E Isolierung und charakterisierung eines lipasehemmstoffes aus lipiden von Arachis hypogaea Hoppe- Seyler’s Zeitschrift fur Physiologische Chemie 1972 353 855 860 5052944
   PubMedGoogle Scholar
• Moreno DA Ilic N Poulev A Raskin I Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters Life Sci 2006 78 2797 2803 16337240
   PubMed Web of Science ®Google Scholar
• Yoshikawa M Murakami T Shimada H Salacinol, potent antidiabetic principle with unique thiosugar sulfonium sulfate structure from the Ayurvedic traditional medicine Salacia reticulata in Sri Lanka and India Tetrahedron Lett 1997 38 8367 8370
   Web of Science ®Google Scholar
• Yoshikawa M Murakami T Yashiro K Matsuda H Kotalanol, a potent alpha-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata Chem Pharm Bull (Tokyo) 1998 46 1339 1340 9734318
   PubMed Web of Science ®Google Scholar
• Yoshikawa M Shimoda H Nishida N Takada M Matsuda H Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats J Nutr 2002 132 1819 1824 12097653
   PubMed Web of Science ®Google Scholar
• Han LK Sumiyoshi M Zhang J Anti-obesity action of Salix matsudana leaves (Part 1). Anti-obesity action by polyphenols of Salix matsudana in high fat-diet treated rodent animals Phytother Res 2003 17 1188 1194 14669254
   PubMed Web of Science ®Google Scholar
• Han LK Sumiyoshi M Zheng YN Okuda H Kimura Y Anti-obesity action of Salix matsudana leaves (Part 2). Isolation of anti-obesity effectors from polyphenol fractions of Salix matsudana Phytother Res 2003 17 1195 1198 14669255
   PubMed Web of Science ®Google Scholar
• Han L Nose R Li W Reduction of fat storage in mice fed a high-fat diet long term by treatment with saponins prepared from Kochia scoparia fruit Phytother Res 2006 20 877 882 16892459
   PubMed Web of Science ®Google Scholar